Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.37 |
| ▸ | FDPS | P14324 | 3/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.35 |
| ▸ | PPARD | Q03181 | 1/20 | 0.35 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.35 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2139902 | 1.00 | LMNA (0.41) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL2140719 | 1.00 | LMNA (0.41) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL2137295 | 1.00 | LMNA (0.41) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL9656413 | 1.00 | LMNA (0.41) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL1699698 | 1.00 | LMNA (0.41) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL11285372 | 1.00 | LMNA (0.41) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL3395197 | 1.00 | LMNA (0.41) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL290240 | 1.00 | LMNA (0.41) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL148380 | 0.95 | DNM1 (0.40) | LMNADNM1TSHRTHRBOPRM1 | |
| SCHEMBL19922801 | 0.95 | DNM1 (0.40) | LMNADNM1TSHRTHRBOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3394035-A1 | USE OF SUBSTITUTED DIHYDROISOQUINOLINIUM SALTS FOR TREATING KERATIN MATERIALS, COMPOSITIONS AND IMPLEMENTATION PROCESSES | L'Oréal (FR) | 2018-10-31 | — | — | EP | disclosed |
| EP-3394034-A1 | USE OF DIHYDROISOQUINOLINIUM SALTS FOR TREATING KERATIN MATERIALS, COMPOSITIONS AND IMPLEMENTATION PROCESSES | L'Oréal (FR) | 2018-10-31 | — | — | EP | disclosed |
| EP-1937734-B1 | BIOCIDAL POLYMERS | KE KELIT KUNSTSTOFFWERK GES M B H (AT) | 2018-04-04 | — | — | EP | disclosed |
| WO-2017109185-A1 | USE OF SUBSTITUTED DIHYDROISOQUINOLINIUM SALTS FOR TREATING KERATIN MATERIALS, COMPOSITIONS AND IMPLEMENTATION PROCESSES | L'OREAL (FR) | 2017-06-29 | — | — | WO | disclosed |
| WO-2017109183-A1 | USE OF DIHYDROISOQUINOLINIUM SALTS FOR TREATING KERATIN MATERIALS, COMPOSITIONS AND IMPLEMENTATION PROCESSES | L'OREAL (FR) | 2017-06-29 | — | — | WO | disclosed |
| WO-2014118231-A2 | DYE COMPOSITION USING AT LEAST ONE COUPLER OF META-AMINOPHENOL TYPE IN A MEDIUM COMPRISING A FATTY SUBSTANCE, PROCESSES AND DEVICE | L'OREAL (FR) | 2014-08-07 | — | — | WO | disclosed |
| EP-2707384-A1 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF | Apellis Pharmaceuticals, Inc. (US) | 2014-03-19 | — | — | EP | disclosed |
| EP-2542210-A2 | COSMETIC ANTIDANDRUFF COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A SECOND, DIFFERENT ACTIVE COMPOUND IN A SPECIFIC WEIGHT RATIO | L'Oréal (FR) | 2013-01-09 | — | — | EP | disclosed |
| WO-2012155107-A1 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF | APELLIS PHARMACEUTICALS, INC. (US) | 2012-11-15 | — | — | WO | disclosed |
| US-8148484-B2 | Poly(bicyclo[2.2.1]hept-5-ene-2-carboxylic acid 2-(tert-butylamino)ethyl ester); Poly(bicyclo[2.2.1]hept-5-ene-2-carboxylic acid 2-(dimethylamino)ethyl ester); used for disinfecting, sterilizing, and preventing biofouling in closed or open industrial-water systems and cooling-water systems | KE KELIT KUNSTSTOFFWERK GESMBH (AT) | 2012-04-03 | — | — | US | disclosed |
| WO-2011107468-A2 | COSMETIC ANTIDANDRUFF COMPOSITION BASED ON ELLAGIC ACID OR A DERIVATIVE THEREOF AND A SECOND, DIFFERENT ACTIVE COMPOUND IN A SPECIFIC WEIGHT RATIO | L'OREAL (FR) | 2011-09-09 | — | — | WO | disclosed |
| US-20080251460-A1 | Biocidal Polymers | KE KELIT KUNSTSTOFFWERK GESMBH (AT) | 2008-10-16 | — | — | US | disclosed |
| EP-1937734-A2 | BIOCIDAL POLYMERS | KE-KELIT Kunststoffwerk Gesellschaft m.b.H. (AT) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007045634-A2 | BIOCIDAL POLYMERS | KE KELIT KUNSTSTOFFWERK GESMBH (AT) | 2007-04-26 | — | — | WO | disclosed |
| EP-0842196-A1 | CELL ADHESION INHIBITORS | BIOGEN, INC. (US) | 1998-05-20 | — | — | EP | disclosed |
| WO-1995035088-A1 | COSMETIC AND/OR PHARMACEUTICAL O/W EMULSIONS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1995-12-28 | — | — | WO | disclosed |
| US-5474778-A | Contains at least one sterol ester in molecule; emulsifying and hydrating qualities | AJINOMOTO CO., INC. (JP) | 1995-12-12 | — | — | US | disclosed |